• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌边缘微环境中 CD8 T 细胞诱导 PD-L1 巨噬细胞的组织空间分析。

Histological spatial analysis on the induction of PD-L1 macrophages by CD8 T cells at the marginal microenvironment of triple-negative breast cancer.

机构信息

Department of Pathology, Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.

Department of Surgery 1, Faculty of Medicine, Yamagata University, Yamagata, Japan.

出版信息

Breast Cancer. 2023 Nov;30(6):1094-1104. doi: 10.1007/s12282-023-01507-9. Epub 2023 Oct 4.

DOI:10.1007/s12282-023-01507-9
PMID:37792212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10587303/
Abstract

BACKGROUND

Programmed death-ligand 1 (PD-L1) plays important roles in the evasion of antitumor immunity. Because we observed the localization of PD-L1-positive (PD-L1) cells in the marginal region of triple-negative breast cancer (TNBC) specimens, we hypothesized that the marginal microenvironment of TNBC would involve the induction of PD-L1 cells.

METHODS

One hundred and one TNBC surgical specimens were examined. We performed immunohistochemical (IHC) studies of PD-L1, CD68, CD8, and pan-cytokeratin in these specimens. We analyzed the localization of IHC-positive cells and the distance between these cells by histological spatial analysis.

RESULTS

In 30.7% of TNBC specimens, PD-L1 cells were located in the marginal region. Approximately three PD-L1 cells accumulated around a single TNBC cell. Most PD-L1 cells were located within 50 μm of TNBC cells. PD-L1 cells were indicated to interact with TNBC cells in the marginal region. PD-L1CD68 cells were located in the marginal region, while CD68 macrophages (MΦs) were observed either in the marginal region or the core region. PD-L1 expression in MΦs was induced in the marginal region. The colocalization of CD8 T cells in the marginal region indicates that PD-L1 expression in MΦs would be induced by interaction with CD8 T cells. Because CD8 T cells are positive for CCL2, CCL2 may induce PD-L1 expression in MΦs.

CONCLUSION

At the marginal microenvironment of TNBC, PD-L1 expression would be induced in MΦs by interaction with CD8 T cells through CCL2. The interaction between PD-L1 MΦs and TNBC cells would facilitate the growth of TNBC under antitumor immunity. These interactions would be potential targets for restoring antitumor immunity and suppressing TNBC progression.

摘要

背景

程序性死亡配体 1(PD-L1)在逃避抗肿瘤免疫中发挥重要作用。由于我们观察到三阴性乳腺癌(TNBC)标本中 PD-L1 阳性(PD-L1)细胞位于边缘区域,我们假设 TNBC 的边缘微环境将涉及 PD-L1 细胞的诱导。

方法

检查了 101 例 TNBC 手术标本。我们对这些标本进行了 PD-L1、CD68、CD8 和细胞角蛋白的免疫组织化学(IHC)研究。我们通过组织学空间分析分析了 IHC 阳性细胞的定位和这些细胞之间的距离。

结果

在 30.7%的 TNBC 标本中,PD-L1 细胞位于边缘区域。大约三个 PD-L1 细胞聚集在单个 TNBC 细胞周围。大多数 PD-L1 细胞位于 TNBC 细胞 50μm 范围内。PD-L1 细胞被指示与边缘区域的 TNBC 细胞相互作用。PD-L1CD68 细胞位于边缘区域,而 CD68 巨噬细胞(MΦ)则位于边缘区域或核心区域。MΦ 中的 PD-L1 表达在边缘区域被诱导。边缘区域 CD8 T 细胞的共定位表明,MΦ 中的 PD-L1 表达将通过与 CD8 T 细胞的相互作用而被诱导。由于 CD8 T 细胞对 CCL2 呈阳性,CCL2 可能诱导 MΦ 中的 PD-L1 表达。

结论

在 TNBC 的边缘微环境中,通过 CCL2 与 CD8 T 细胞的相互作用,PD-L1 在 MΦ 中被诱导表达。PD-L1 MΦ 与 TNBC 细胞之间的相互作用将促进抗肿瘤免疫下 TNBC 的生长。这些相互作用可能成为恢复抗肿瘤免疫和抑制 TNBC 进展的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/78ae38e0514a/12282_2023_1507_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/179e434b33af/12282_2023_1507_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/b0388b895326/12282_2023_1507_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/546732d9e3ab/12282_2023_1507_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/bdf214f0e3ce/12282_2023_1507_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/2324a2b7d878/12282_2023_1507_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/0cf21c0a7359/12282_2023_1507_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/78ae38e0514a/12282_2023_1507_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/179e434b33af/12282_2023_1507_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/b0388b895326/12282_2023_1507_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/546732d9e3ab/12282_2023_1507_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/bdf214f0e3ce/12282_2023_1507_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/2324a2b7d878/12282_2023_1507_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/0cf21c0a7359/12282_2023_1507_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a275/10587303/78ae38e0514a/12282_2023_1507_Fig7_HTML.jpg

相似文献

1
Histological spatial analysis on the induction of PD-L1 macrophages by CD8 T cells at the marginal microenvironment of triple-negative breast cancer.三阴性乳腺癌边缘微环境中 CD8 T 细胞诱导 PD-L1 巨噬细胞的组织空间分析。
Breast Cancer. 2023 Nov;30(6):1094-1104. doi: 10.1007/s12282-023-01507-9. Epub 2023 Oct 4.
2
Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer.三阴性乳腺癌中与程序性死亡配体1表达相关的肿瘤浸润淋巴细胞的多光谱定量免疫组织化学分析
Breast Cancer. 2020 Jul;27(4):519-526. doi: 10.1007/s12282-020-01110-2. Epub 2020 May 23.
3
Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy.新辅助治疗后不同乳腺癌肿瘤免疫微环境表型的比较。
Cancer Med. 2023 Feb;12(3):2906-2917. doi: 10.1002/cam4.5207. Epub 2022 Sep 8.
4
Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.蒲公英提取物通过抑制 IL-10/STAT3/PD-L1 信号通路抑制肿瘤相关巨噬细胞微环境中三阴性乳腺癌细胞的恶性表型。
J Ethnopharmacol. 2021 Jun 28;274:113978. doi: 10.1016/j.jep.2021.113978. Epub 2021 Mar 11.
5
Histological subtype is associated with PD-L1 expression and CD8+ T-cell infiltrates in triple-negative breast carcinoma.组织学亚型与三阴性乳腺癌中 PD-L1 表达和 CD8+ T 细胞浸润相关。
Ann Diagn Pathol. 2022 Apr;57:151901. doi: 10.1016/j.anndiagpath.2022.151901. Epub 2022 Jan 24.
6
ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC.ALG3 通过调节 TNBC 中 PD-L1 N-连接糖基化来预测不良预后并增加对抗 PD-1 治疗的耐药性。
Int Immunopharmacol. 2024 Oct 25;140:112875. doi: 10.1016/j.intimp.2024.112875. Epub 2024 Aug 9.
7
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.肿瘤基质中高 CD8 与 FOXP3 的比值和肿瘤细胞中 PTEN 的表达与非转移性三阴性乳腺癌患者的生存改善相关。
BMC Cancer. 2021 Aug 6;21(1):901. doi: 10.1186/s12885-021-08636-4.
8
Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.未接受辅助化疗的早期三阴性乳腺癌患者肿瘤浸润淋巴细胞、CD8、CD20、程序性细胞死亡配体 1 和三级淋巴结构的综合预后分析。
Breast Cancer Res Treat. 2023 Jan;197(2):287-297. doi: 10.1007/s10549-022-06787-x. Epub 2022 Nov 16.
9
Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors.ARID1A 低表达导致适应性免疫抵抗,并使三阴性乳腺癌对免疫检查点抑制剂敏感。
Cancer Commun (Lond). 2023 Sep;43(9):1003-1026. doi: 10.1002/cac2.12465. Epub 2023 Jul 11.
10
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes.不同治疗初治乳腺癌亚型中,增殖的 CD8+/TCF1+ T 细胞和 CD163+/PD-L1+ 巨噬细胞的特征不同,对复发的预测作用也不同。
Cancer Immunol Immunother. 2024 Feb 13;73(3):46. doi: 10.1007/s00262-024-03630-8.

引用本文的文献

1
Orchestration of Tumor-Associated Macrophages in the Tumor Cell-Macrophage-CD8 T Cell Loop for Cancer Immunotherapy.肿瘤细胞-巨噬细胞-CD8 T细胞循环中肿瘤相关巨噬细胞的调控用于癌症免疫治疗
Int J Biol Sci. 2025 Jun 12;21(9):4098-4116. doi: 10.7150/ijbs.115932. eCollection 2025.
2
Activation of fibroblasts by plasma cells via PDGF/PDGFR signaling in IgG4-related sialadenitis.浆细胞通过 PDGF/PDGFR 信号激活 IgG4 相关唾液腺炎中的成纤维细胞。
J Clin Exp Hematop. 2024;64(3):223-231. doi: 10.3960/jslrt.24040.
3
Mechanisms of lymphoma-stromal interactions focusing on tumor-associated macrophages, fibroblastic reticular cells, and follicular dendritic cells.

本文引用的文献

1
Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer.影响三阴性乳腺癌肿瘤微环境和预后的关键基因的鉴定
Front Oncol. 2021 Oct 21;11:746058. doi: 10.3389/fonc.2021.746058. eCollection 2021.
2
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.空间免疫表型可预测抗 PD-1 治疗反应,并捕获三阴性乳腺癌中 T 细胞逃逸的不同途径。
Nat Commun. 2021 Sep 27;12(1):5668. doi: 10.1038/s41467-021-25962-0.
3
Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
淋巴瘤-基质相互作用的机制,重点关注肿瘤相关巨噬细胞、纤维网状细胞和滤泡树突状细胞。
J Clin Exp Hematop. 2024 Sep 28;64(3):166-176. doi: 10.3960/jslrt.24034. Epub 2024 Jul 31.
CCL2-CCR2 信号轴在癌症中的作用:机制与治疗靶点。
Cell Prolif. 2021 Oct;54(10):e13115. doi: 10.1111/cpr.13115. Epub 2021 Aug 31.
4
Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling.肿瘤相关巨噬细胞衍生的转化生长因子-β通过 HIF1-TRIB3 信号促进结直肠癌的进展。
Cancer Sci. 2021 Oct;112(10):4198-4207. doi: 10.1111/cas.15101. Epub 2021 Aug 23.
5
Regulation of PD-L1 expression in the tumor microenvironment.肿瘤微环境中 PD-L1 表达的调控。
J Hematol Oncol. 2021 Jan 7;14(1):10. doi: 10.1186/s13045-020-01027-5.
6
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.帕博利珠单抗联合化疗对比安慰剂联合化疗用于治疗既往未经治疗的局部晚期不可切除或转移性三阴性乳腺癌(KEYNOTE-355):一项随机、安慰剂对照、双盲、III 期临床研究。
Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9.
7
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.阻断CCL2表达可克服转谷氨酰胺酶2诱导的PD-L1阳性三阴性乳腺癌中固有的PD-1/PD-L1抑制剂耐药性。
Am J Cancer Res. 2020 Sep 1;10(9):2878-2894. eCollection 2020.
8
Cytotoxic CD8 T cells in cancer and cancer immunotherapy.癌症与癌症免疫治疗中的细胞毒性 CD8 T 细胞。
Br J Cancer. 2021 Jan;124(2):359-367. doi: 10.1038/s41416-020-01048-4. Epub 2020 Sep 15.
9
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.三阴性乳腺癌中肿瘤间质浸润免疫细胞中 PD-L1(SP142)表达的临床和病理特征。
Mod Pathol. 2020 Nov;33(11):2221-2232. doi: 10.1038/s41379-020-0606-0. Epub 2020 Jul 1.
10
Breast Cancer Cell-Derived Soluble CD44 Promotes Tumor Progression by Triggering Macrophage IL1β Production.乳腺癌细胞衍生的可溶性 CD44 通过触发巨噬细胞 IL1β 产生促进肿瘤进展。
Cancer Res. 2020 Mar 15;80(6):1342-1356. doi: 10.1158/0008-5472.CAN-19-2288. Epub 2020 Jan 22.